Daily Stock Analysis, BLFS, BioLife Solutions Inc, priceseries

BioLife Solutions Inc. Daily Stock Analysis
Stock Information
Open
19.48
Close
19.09
High
19.55
Low
19.00
Previous Close
19.61
Daily Price Gain
-0.52
YTD High
22.44
YTD High Date
Mar 22, 2019
YTD Low
10.90
YTD Low Date
Jan 3, 2019
YTD Price Change
7.09
YTD Gain
59.08%
52 Week High
22.44
52 Week High Date
Mar 22, 2019
52 Week Low
9.15
52 Week Low Date
Dec 21, 2018
52 Week Price Change
0.01
52 Week Gain
0.05%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Feb 9. 2017
1.84
Feb 23. 2017
1.97
9 Trading Days
7.33%
Link
LONG
Mar 2. 2017
2.01
Mar 10. 2017
2.13
6 Trading Days
6.08%
Link
LONG
Jun 16. 2017
2.28
Jul 20. 2017
3.14
23 Trading Days
37.82%
Link
LONG
Aug 16. 2017
4.17
Sep 11. 2017
4.57
17 Trading Days
9.58%
Link
LONG
Sep 15. 2017
4.85
Oct 3. 2017
5.32
12 Trading Days
9.59%
Link
LONG
Dec 13. 2017
5.64
Dec 29. 2017
5.96
11 Trading Days
5.59%
Link
LONG
Apr 2. 2018
6.18
Apr 24. 2018
7.17
16 Trading Days
16.06%
Link
LONG
May 4. 2018
7.49
Jun 21. 2018
11.85
33 Trading Days
58.28%
Link
LONG
Jul 2. 2018
14.99
Jul 24. 2018
19.35
15 Trading Days
29.12%
Link
LONG
Aug 20. 2018
20.81
Sep 4. 2018
23.61
10 Trading Days
13.45%
Link
LONG
Jan 4. 2019
11.78
Jan 18. 2019
12.38
10 Trading Days
5.12%
Link
LONG
Jan 30. 2019
13.13
Feb 14. 2019
15.41
11 Trading Days
17.37%
Link
LONG
Feb 15. 2019
16.16
Mar 4. 2019
17.14
10 Trading Days
6.08%
Link
LONG
Mar 14. 2019
17.69
Mar 25. 2019
18.68
7 Trading Days
5.59%
Link
LONG
Jul 18. 2019
16.97
Jul 26. 2019
17.93
6 Trading Days
5.68%
Link
Company Information
Stock Symbol
BLFS
Exchange
NasdaqCM
Company URL
http://www.biolifesolutions.com
Company Phone
4254011400
CEO
Michael P. Rice
Headquarters
Washington
Business Address
3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA 98021
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000834365
About

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of portfolio of biopreservation tools for cells, tissues, and organs. Its products include CryoStor, BloodStor, HypoThermosol FRS, Cell Thawing Media, and PrepaStor. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Description

BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues in the United States. The company's products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. It offers HypoThermosol FRS, a hypothermic storage and shipping media product to reduce post-preservation necrosis and apoptosis; CryoStor cryopreservation freeze media products, which are designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing; and BloodStor products comprising BloodStor 55-5 and BloodStor 100 for cryopreservation of cells isolated from umbilical cord blood, peripheral blood, and bone marrow. The company also provides cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. In addition, it offers custom product formulation and custom packaging services; precision thermal packaging products and cloud-hosted Web applications; and contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The company markets its products to the bio banking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. BioLife Solutions, Inc. was founded in 1987 and is based in Bothell, Washington.